Business Wire11.28.17
Samsung Electronics, a developer and global provider of medical imaging technology, is debuting its OmniTom mobile 16-slice computed tomography (CT) scanner this week at the Radiological Society of North America (RSNA) 2017 Annual Meeting in Chicago, Ill. OmniTom received 510(k) U.S. Food and Drug Administration clearance for the U.S. market on Aug. 18.
The release of OmniTom is the latest demonstration of Samsung’s innovations in CT imaging. OmniTom features an array of improvements from Samsung’s CereTom CT scanner, including:
OmniTom is ideal for cranial procedures and is designed to deliver the highest quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom an indispensable tool for collecting real-time data on critically ill patients.
The latest product also demonstrates Samsung’s “AccE” (Access, Accuracy and Efficiency) strategy that aims to change the industry by incorporating innovations in physical access to provide care wherever it is needed. It also aims to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.
“OmniTom embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of Access, Accuracy and Efficiency,” said Dongsoo Jun, president of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “We’ve made a CT product that’s lighter, more mobile, more accurate and faster, and we hope the many doctors and technicians here at RSNA will be able to use it to benefit their patients.”
“At Samsung, we work to make sure that our products provide patients and physicians with the best possible options for care” added Philip Sullivan, president and CEO Samsung NeuroLogica. “We do this through designing products that deliver broad access, superior accuracy and quality, and make care teams more efficient by maximizing throughput and minimizing waste.”
In addition to OmniTom, Samsung is showcasing its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology. Samsung’s team is also demonstrating a range of healthcare solutions in mobile CT, digital radiography and ultrasound that are all designed to bridge the care-delivery gap and maximize efficiency to enhance the patient experience. Such solutions include:
RSNA attendees can learn more about Samsung's imaging solutions by visiting booth 2543 (South Building, Hall A).
Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures and markets imaging technologies. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s portfolio of medical technologies are used worldwide in healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency.
Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems, and memory, system LSI, foundry and LED solutions.
The release of OmniTom is the latest demonstration of Samsung’s innovations in CT imaging. OmniTom features an array of improvements from Samsung’s CereTom CT scanner, including:
- Improved workflow: OmniTom is the world’s first mobile imaging device with omni-directional wheels, maximizing mobility and allowing easier and quieter movement in small spaces.
- Superior image quality: 16-slice (0.625 mm per slice) advanced data acquisition system with effective dose optimization.
- Expanded use: Maintains a small footprint ideal for mobile use while increasing the gantry opening to 40 cm for improved coverage of adult head and neck, and full body pediatric scanning.
- Enhanced safety system: OmniTom features an internal drive system, making portability less strenuous, while also offering smart-sensing collision avoidance software to maximize control and patient safety.
OmniTom is ideal for cranial procedures and is designed to deliver the highest quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom an indispensable tool for collecting real-time data on critically ill patients.
The latest product also demonstrates Samsung’s “AccE” (Access, Accuracy and Efficiency) strategy that aims to change the industry by incorporating innovations in physical access to provide care wherever it is needed. It also aims to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.
“OmniTom embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of Access, Accuracy and Efficiency,” said Dongsoo Jun, president of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “We’ve made a CT product that’s lighter, more mobile, more accurate and faster, and we hope the many doctors and technicians here at RSNA will be able to use it to benefit their patients.”
“At Samsung, we work to make sure that our products provide patients and physicians with the best possible options for care” added Philip Sullivan, president and CEO Samsung NeuroLogica. “We do this through designing products that deliver broad access, superior accuracy and quality, and make care teams more efficient by maximizing throughput and minimizing waste.”
In addition to OmniTom, Samsung is showcasing its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology. Samsung’s team is also demonstrating a range of healthcare solutions in mobile CT, digital radiography and ultrasound that are all designed to bridge the care-delivery gap and maximize efficiency to enhance the patient experience. Such solutions include:
- Ultrasound Segment: Samsung is featuring its general imaging ultrasound portfolio, including the new HS60 and HS40 ultrasound systems that were introduced earlier this year. The RS80A with Prestige, Samsung’s premium general imaging ultrasound system, is being displayed in three daily educational demonstrations featuring live scanning. The RS80A includes technologies for the busy radiology department that help boost clinical confidence. Based on its achievements in ultrasonic diagnosis devices for obstetrics and gynecology, the company is strengthening its premium ultrasonic diagnosis device business for radiology, which has the biggest market potential.
- Digital Radiography Segment: Samsung is displaying a range of its portfolio including two ceiling-mounted systems, GC85 and GC70, as well as highlight its premium portable GM85 X-ray. The GM85’s enhanced mobility and streamlined workflow enable users to experience a new level of efficiency along with exceptional image quality. Samsung has also differentiated itself from its competitors by adopting low dose technology for enhanced patient safety.
- Magnetic Resonance Imaging Segment: Samsung is showcasing a prototype of Specialty MRI, an MRI imaging device for arms and/or legs. The prototype is expected to be a game changer in the industry: It is designed to maximize not only cost and space but also patient convenience, as it eliminates the need for the whole body to be in the MRI device.
RSNA attendees can learn more about Samsung's imaging solutions by visiting booth 2543 (South Building, Hall A).
Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures and markets imaging technologies. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s portfolio of medical technologies are used worldwide in healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency.
Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems, and memory, system LSI, foundry and LED solutions.